Skip to main content

Table 3 Post-treatment patient characteristics

From: The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

Characteristics All patients 23 (100%)a NR 7 (30%) PR 10 (43%) TR 6 (26%) p valueb
Tumor diff. after treatment      0.064
 No surgery 3 (13) 0 0 3 (50)  
 Missing value 5 (22) 2 (29) 1 (10) 2 (33)  
 Well 5 (22) 1 (14) 4 (40) 0  
 Moderately 9 (39) 3 (43) 5 (50) 1 (17)  
 Undifferentiated 1 (4) 1 (14) 0 0  
Post-treatment stage      3.3e−08
 0 6 (26) 0 0 6 (100)  
 I 7 (30) 0 7 (70) 0  
 IIA 3 (13) 2 (29) 1 (10) 0  
 IIIA 2 (9) 0 2 (20) 0  
 IIIB 2 (9) 2 (29) 0 0  
 IIIB–IIIC 3 (13) 3 (43) 0 0  
ypT      4.6e−08
 T0 6 (26) 0 0 6 (100)  
 T1 3 (13) 0 3 (30) 0  
 T2 6 (26) 0 6 (60) 0  
 T3 7 (30) 6 (86) 1 (10) 0  
 T4 1 (4) 1 (14) 0 0  
PNI      1
 + 2 (9) 1 (14) 1 (10) 0  
 − 21 (91) 6 (86) 9 (90) 6 (100)  
LVI      0.002
 + 8 (35) 6 (86) 2 (20) 0  
 − 15 (65) 1 (14) 8 (80) 6 (100)  
  1. LVI lymphovascular invasion, NR non-responders, PNI perineural invasion, PR partial responders, TR total responders, ypT post-treatment tumor
  2. aFirst number: number of patients; number in parentheses: percentage of patients
  3. bThe p value is obtained by Fisher’s exact test and is considered significant when p value < 0.05